Higher prevalence was seen for antiviral-treated patients compared with untreated counterparts. (HealthDay News) — Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic ...

As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...

CKD is a widespread condition that not only increases the risk of kidney failure but also significantly raises the risk of developing various forms of cardiovascular disease. A re ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

"The pervasive presence of phthalates results in nearly unavoidable exposure in the general population, with CKD patients likely experiencing even higher levels due to their medical treatment ...

Chronic kidney disease (CKD) is correlated with sudden cardiac death (SCD), according to an October study published in Nature Communications.

Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD ...

ProKidney Corp. (Nasdaq: PROK) ('ProKidney” or the 'Company'), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

The US FDA has granted approval for Roche's Gazyva/ Gazyvaro to treat adult patients with active LN who are on standard ...

As the lights went out in her hometown, 40-year-old Zinaida Kot could not help but think about her next dialysis treatment ...